MCID: ENC002
MIFTS: 21

Eunuchism

Categories: Endocrine diseases

Aliases & Classifications for Eunuchism

MalaCards integrated aliases for Eunuchism:

Name: Eunuchism 12 44 17 72

Classifications:



External Ids:

Disease Ontology 12 DOID:5003
MeSH 44 D005058
UMLS 72 C0238117

Summaries for Eunuchism

Disease Ontology : 12 A hypogonadism that is characterized by the lack of mature male germ cells and testicular hormones.

MalaCards based summary : Eunuchism is related to hypogonadotropic hypogonadism 23 without anosmia and hypogonadism. The drugs Estradiol and Polyestradiol phosphate have been mentioned in the context of this disorder. Affiliated tissues include testes and testis.

Related Diseases for Eunuchism

Graphical network of the top 20 diseases related to Eunuchism:



Diseases related to Eunuchism

Symptoms & Phenotypes for Eunuchism

Drugs & Therapeutics for Eunuchism

Drugs for Eunuchism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 47)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
2
Polyestradiol phosphate Approved Phase 4 28014-46-2
3
Testosterone enanthate Approved Phase 4 315-37-7 9416
4
Methyltestosterone Approved Phase 4 58-18-4 6010
5
Testosterone Approved, Experimental, Investigational Phase 4 481-30-1, 58-22-0 6013 10204
6
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
7 insulin Phase 4
8 Insulin, Globin Zinc Phase 4
9 Follicle Stimulating Hormone Phase 4
10 Estradiol 17 beta-cypionate Phase 4
11 Estradiol 3-benzoate Phase 4
12 Androgens Phase 4
13 Hormones Phase 4
14 Anabolic Agents Phase 4
15 Antineoplastic Agents, Hormonal Phase 4
16 Hormone Antagonists Phase 4
17 Testosterone 17 beta-cypionate Phase 4
18 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
19 Pharmaceutical Solutions Phase 4
20
Coal tar Approved Phase 3 8007-45-2
21
Dihydrotachysterol Approved Phase 2 67-96-9 5311071 5281010
22
Dutasteride Approved, Investigational Phase 2 164656-23-9 152945 6918296
23
Sodium citrate Approved, Investigational Phase 2 68-04-2
24
Anastrozole Approved, Investigational Phase 2 120511-73-1 2187
25
Finasteride Approved Phase 2 98319-26-7 57363
26
tannic acid Approved Phase 1, Phase 2 1401-55-4
27
Benzocaine Approved, Investigational Phase 1, Phase 2 94-09-7, 1994-09-7 2337
28
Calcium Approved, Nutraceutical Phase 2 7440-70-2 271
29
Citric acid Approved, Nutraceutical, Vet_approved Phase 2 77-92-9 311
30
Enclomiphene Investigational Phase 2 15690-57-0
31 Chelating Agents Phase 2
32 Anticoagulants Phase 2
33 Calcium, Dietary Phase 2
34 5-alpha Reductase Inhibitors Phase 2
35 Steroid Synthesis Inhibitors Phase 2
36 Selective Estrogen Receptor Modulators Phase 2
37 Fertility Agents Phase 2
38 Estrogens Phase 2
39 Citrate Phase 2
40 Clomiphene Phase 2
41 Estrogen Receptor Modulators Phase 2
42 Estrogen Receptor Antagonists Phase 2
43 Estrogen Antagonists Phase 2
44 Zuclomiphene Phase 2
45 Aromatase Inhibitors Phase 2
46 Deslorelin Investigational, Vet_approved 57773-65-6
47 Chorionic Gonadotropin

Interventional clinical trials:

(show all 25)
# Name Status NCT ID Phase Drugs
1 Subcutaneous Testosterone Therapy in Men Compared to Intramuscular Testosterone Therapy in Men Completed NCT03091348 Phase 4 Testosterone
2 Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Completed NCT03792321 Phase 4 Testosterone Undecanoate;Placebo
3 Clinical, Microbiologic and Immunologic Profile of the Periodontal Condition in Hypogonadic Men Recruiting NCT03176537 Phase 4 Testosterone gel;Placebos
4 Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters Recruiting NCT03203681 Phase 4 NATESTO® (4.5% nasal testosterone) Nasal Gel
5 Improving Patient-Important Outcomes With Testosterone Replacement in Hypogonadal Men With a Prior History of Cancer Not yet recruiting NCT04049331 Phase 4 Testosterone cypionate 125 mg/week
6 52 Week RCT to Investigate the Effect of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Obese Men With T2DM and Hypogonadism and Subsequent 108 Week Open Label Phase to Investigate Effects on Cardiometabolic Parameters Not yet recruiting NCT03851627 Phase 4 Testosterone Undecanoate;Placebo
7 Validation of Dosing Regimen of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men. Completed NCT03242590 Phase 3 LPCN 1021
8 Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men. Completed NCT03242408 Phase 3 LPCN 1021
9 Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men Completed NCT02081300 Phase 3 Oral testosterone undecanoate, LPCN 1021;Topical testosterone gel 1.62 %
10 Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men Completed NCT01765179 Phase 3 Oral testosterone undecanoate
11 A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating the Efficacy and Safety of Intranasal TBS-1 in the Treatment of Male Hypogonadism With Sequential Safety Extension Periods of 90 and 180 Days Completed NCT01446042 Phase 3 Testosterone;Testosterone
12 Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men Completed NCT03868059 Phase 3 LPCN 1021
13 Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Completed NCT01403116 Phase 3 Oral testosterone undecanoate;topical testosterone gel
14 A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne) Recruiting NCT03198728 Phase 3 SOV2012-F1;AndroGel
15 A Comparison of Clomiphene Citrate Responses in Men With Hypothalamic Hypogonadism naïve to, and Previously Treated With, Testosterone Unknown status NCT01904734 Phase 2 Clomiphene
16 A Phase II, 28-Day, Randomized, Parallel-Group, Open-Label Study Evaluating the Efficacy and Safety of Twice Daily Oral Doses of Testosterone (150-400mg) Co-administered With 0.25mg Dutasteride Compared With 400mg Testosterone Alone and 0.25mg Dutasteride Alone in the Treatment of Hypogonadism Completed NCT00398580 Phase 2 Nanomilled testosterone;Nanomilled dutasteride;commercially available dutasteride
17 A Randomized Double Blinded Placebo Controlled Trial Between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile Function Using ADAM, IIEF and EHS Validated Scales Completed NCT03933618 Phase 2 Anastrozole 1mg;Clomiphene Citrate 25mg;Placebo - Cap
18 5-Alpha Reductase and Anabolic Effects of Testosterone Completed NCT00475501 Phase 2 Testosterone Enanthate;Finasteride
19 A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males Terminated NCT03335254 Phase 1, Phase 2 TSX-011
20 An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components Completed NCT00400335 Phase 1 Nanomilled testosterone;commercially available dutasteride;Nanomilled dutasteride
21 A Study to Assess Post-collection Conversion of Testosterone Undecanoate (TU) to Testosterone in Blood From Men Receiving Oral TU Collected Into Different Types of Sample Tubes Completed NCT03973840 Phase 1 Testosterone Undecanoate
22 Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males Before and After Pharmacological Castration Completed NCT03541395 GnRH antagonist
23 Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male (ADAM) Recruiting NCT03282682
24 Gonadal Function in Young to Middle Aged HIV-infected Men Assessed by Isotopic Dilution-liquid Chromatography-mass Spectrometry (ID-LC-MS/MS) and Chemiluminescent Immunoassay Active, not recruiting NCT03747003
25 Calciotropic Effects After hCG Stimulation Test Active, not recruiting NCT03254641 human chorionic gonadotropin

Search NIH Clinical Center for Eunuchism

Cochrane evidence based reviews: eunuchism

Genetic Tests for Eunuchism

Anatomical Context for Eunuchism

MalaCards organs/tissues related to Eunuchism:

41
Testes, Testis

Publications for Eunuchism

Articles related to Eunuchism:

(show all 29)
# Title Authors PMID Year
1
[Henry IV of Castilla (1454-1474). An exceptional urologic patient. An endocrinopathy causing the uro-andrological problems of the Monarch. Artificial insemination attempts (IV)]. 38
12768985 2003
2
Congenital eunuchism and Favorinus. 38
12564336 2003
3
[Eunuchism in Byzantium]. 38
11761705 2001
4
Hemicorporectomy. 38
7712321 1995
5
Eunuchs and eunuchism - an historical discourse. Part II - Civil law. 38
11611120 1982
6
[Hypogonadism with spermatogenesis (fertile eunuch syndrome) (author's transl)]. 38
6283650 1982
7
Eunuchs and eunuchism--an historical discourse. 38
11610953 1981
8
[Myocardial infarct with failure of mitral valve papillary muscle in a case of eunuchism]. 38
463000 1979
9
[Is eunuchism a question of testostererone deficiency?]. 38
5561796 1971
10
[Feminine hypogonadotrophic eunuchism]. 38
5495948 1970
11
[An XY eunuchism syndrome with preserved spermatogenesis and normal secretion of FSH, ICSH and testosterone. Preliminary report]. 38
5408621 1969
12
[Different histological patterns of the testis in cases of hypogonadotrophic eunuchism]. 38
5407617 1969
13
[Eunuchism with spermatogenesis; a rare cause of male subfertility]. 38
5679596 1968
14
[Histopathologic pictures of testes in hypogonadotropic eunuchism]. 38
6050709 1967
15
[Hypogonadotropic eunuchism in women]. 38
6050708 1967
16
[Idiopathic hypogonadotrophic eunuchism and anosmia]. 38
5302876 1967
17
[IDIOPATHIC HYPOGONADOTROPIC EUNUCHISM. STUDY OF 24 CASES]. 38
14202711 1964
18
[APROPOS OF A CASE OF LOBSTEIN'S DISEASE ASSOCIATED WITH A EUNUCHISM SECONDARY TO A CRYPTORCHISM]. 38
14144046 1964
19
[Therapy of eunuchism]. 38
13985337 1962
20
Serum inorganic phosphorus levels in eunuchism and in feeble-minded states. 38
13502447 1958
21
Anorchism without eunuchism. 38
13346829 1956
22
[Hypergonadotropic eunuchism (Klinefelter syndrome)]. 38
13349173 1956
23
[A case of hypogonadotrophic female eunuchism; ovarian biopsy]. 38
13181045 1954
24
Clinical and endocrinological investigations in a case of eunuchism (gigantism with hypogonadism). 38
14877571 1951
25
[Osteoporosis in eunuchism]. 38
14793841 1950
26
[Diffuse decalcifying osteosis and eunuchism]. 38
15441783 1950
27
The clinical significance of urinary 17-ketosteroid assays. 38
15405026 1950
28
The cultural aspects of eunuchism. 38
20276292 1946
29
Male Eunuchism Considered in the Light of the Historical Method. 38
19993336 1946

Variations for Eunuchism

Expression for Eunuchism

Search GEO for disease gene expression data for Eunuchism.

Pathways for Eunuchism

GO Terms for Eunuchism

Sources for Eunuchism

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....